Cancer Research Annual Meeting 2010 Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 3045-3048, July 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Marchand, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Marchand, L. L.
[Cancer Research 59, 3045-3048, July 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Association of the NAD(P)H:quinone Oxidoreductase 609C->T Polymorphism with a Decreased Lung Cancer Risk1

Hongwei Chen, Annette Lum, Ann Seifried, Lynne R. Wilkens and Loïc Le Marchand2

Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813


   ABSTRACT
Top
 ABSTRACT
Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
The NAD(P)H:quinone oxidoreductase gene, NQO1, often carries a C->T transition at bp 609, which has been associated with a reduced enzymatic activity and which may result in altered metabolic activation of tobacco smoke procarcinogens. We tested the association of this polymorphism with lung cancer risk in a population-based case-control study of 327 cases and 440 controls of Caucasian, Japanese, or Native Hawaiian ancestry in Hawaii. We found a notable difference in the frequency of the variant allele among Japanese (38%), Caucasians (20%), and Hawaiians (22%). Overall, the variant allele was less frequent in cases than in controls (P= 0.03). A significant inverse association was found in Japanese, with adjusted odds ratios of 0.8 (95% confidence interval, 0.4–5) and 0.3 (0.1–7) for the heterozygous and homozygous variant genotypes, respectively, compared with the homozygous wild-type genotype (P for genetic trend, 0.02). The association did not reach statistical significance in Caucasians and Hawaiians but was in the same direction.


   Introduction
Top
 ABSTRACT
 Introduction
Materials and Methods
 Results
 Discussion
 REFERENCES
 
Lung cancer, the leading cause of cancer death in the United States, shows marked ethnic/racial variation in incidence (1) , which may not be completely due to differences in smoking habits (2) . It has been suggested that interindividual variation in the metabolism of tobacco carcinogens may determine susceptibility to lung cancer (3) . The frequency of a number of genetic polymorphisms associated with altered capacity to metabolically activate or detoxify tobacco procarcinogens has been found to vary markedly across ethnic/racial groups. Some of these polymorphisms have been associated with lung cancer risk (4, 5, 6) .

NQO1,3 formerly referred to as DT diaphorase, is an important enzyme in the metabolism of xenobiotics. It may act as either a detoxification or activation enzyme, depending on the substrate (7 , 8) . For example, it catalyzes the two-electron reduction of quinoid compounds to the readily excreted hydroquinones, preventing the generation of free radicals and reactive oxygen, thus protecting cells from oxidative damage (9) . Alternatively, NQO1 is known to catalyze the activation of some environmental procarcinogens present in tobacco smoke, such as nitroaromatic compounds and heterocyclic amines (7 , 10 , 11) .

A C->T base transition mutation at position 609 of the NQO1 cDNA has been associated with reduced enzymatic activity (12) and shown to be present in 13–25% of the white population (13) . Two previous studies on the association between this polymorphism and lung cancer risk yielded contradictory results, although the studies included different ethnic groups and were not population based (14 , 15) . Considering its potential role in the modulation of tobacco procarcinogens, we tested the hypothesis that the NQO1 609C->T polymorphism is associated with lung cancer risk in a population-based case-control study of 767 Caucasians, Japanese, and Native Hawaiians in Hawaii.


   Materials and Methods
Top
 ABSTRACT
 Introduction
 Materials and Methods
Results
 Discussion
 REFERENCES
 
Lung cancer patients were identified by the rapid-reporting system of the Hawaii Tumor Registry, a member of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Eligible cases were all patients with histologically confirmed primary lung cancer who were diagnosed between January 1, 1992 and March 31, 1997, in all main medical centers on the island of Oahu, Hawaii. Other eligibility criteria included age between 26 and 79 years, Oahu residency, no previous history of lung cancer, and ethnicity (>=75% Japanese, >=75% Caucasian, any Hawaiian/part-Hawaiian heritage). An interview was completed for 64% of the eligible cases. The main reasons for nonparticipation were patient refusal (17%), physician refusal (2%), and death with absence of a suitable surrogate for interview (17%).

Controls were randomly selected from a list of Oahu residents interviewed by the State of Hawaii Department of Health as part of a health survey of a 2% random sample of state households. This source was supplemented with controls over age 65 from Health Care Financing Administration participants on Oahu. One control was matched to each case on sex, ethnicity, and age (±2 years). The overall participation rate for the controls was 62%. Reasons for nonparticipation included refusal (25%), inability to locate (10%), serious illness (1%), and death (2%). The analysis presented here was conducted with the 341 cases (76% of interviewed cases) and 456 population controls (80% of interviewed controls) who donated a blood specimen for the study.

In-person interviews were conducted at the subjects’ homes by trained interviewers. On average, cases were interviewed within 4 months of diagnosis. The questionnaire included detailed demographic information, including ethnic origin of each grandparent, a lifetime history of tobacco and alcohol use, a quantitative food frequency questionnaire, various relevant medical conditions and occupational exposures, and a family history of lung diseases(6) . Information was collected on the types (nonfiltered cigarettes, filtered cigarettes, cigars, and pipes) of tobacco product ever smoked daily for at least 6 months and, for each tobacco product, the usual amount per day, age when started, the overall duration of use, and for ex-smokers, age when smoking stopped. We also inquired about any periods of smoking cessation for each tobacco product during the subject‘s life. Laboratory personnel were blinded to the case-control status of the subjects. DNA was purified from peripheral blood lymphocytes by standard SDS/proteinase K treatment and phenol/chloroform extraction. A PCR-RFLP based assay was used to characterize the wt and vt NQO1 alleles. Using a Perkin-Elmer Corp. 9600 thermocycler, PCR products were generated using 100 ng of genomic DNA as template. The sense primer (5'-TCCTCAGAGTGGCATTCTGC-3') and antisense primer (5'-TCTCCTCATCCTGTACCTCT-3') amplify a 230-bp oligonucleotide including the NQO1609->T polymorphism. This C->T transition creates a new HinfI restriction site that is used to distinguish the vt from the wt allele. The PCR reaction was carried out using a 30ul reaction with a final concentration of 50 u mm deoxynucleotide triphosphates, 2.5 mm MgCl2, 1.0 um for each primer, and 1 unit of Taq polymerase. After an initial denaturation at 94°C for 4 min, the cycling conditions were as follows: 2 cycles at 94°C for 15 s, 69°C for 15 s, and 72°C for 30 s; 2 cycles at 94°C for 15 s, 67°C for 15 s, and 72°C for 30 s; 31 cycles at 94°C for 30 s, 65°C for 30 s, and 72°C for 1 min; and finally an extension at 72°C for 5 min. The PCR products were then digested with 5 units of HinfI for 3 h at 37°C. The genotype pattern for each PCR product was detected by electrophoresis on a 1.8% agarose gel containing 0.5 ug/ml ethidium bromide (Fig. 1)Citation . Each gel included an uncut PCR product as control. Complete digestion of the 230-bp PCR product gave a cut fragment of 195 bp for the wt allele and of 151 bp for the vt allele.



View larger version (33K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. Genotype pattern for NQO1 gene polymorphism analyzed by PCR. Lane M, HinfI-digested {phi}-X174 DNA molecular weight marker; Lane 1, wt; Lane 2, heterozygous; Lane 3, homozygous mutant; Lane 4, uncut PCR product; Lane 5, negative control. The 151-bp fragment indicates the vt allele.

 
The statistical analysis used the {chi}2 statistic for homogeneity to test for case-control differences in the distribution of the genotypes or other parameters under study. Unconditional logistic regression (16) was used to compute ORs and 95% CIs, with adjustment for several covariates found associated with risk (sex and race, using indicator variables; age, smoking duration and amount, and saturated fat and total vegetable intakes, as continuous variables). Several ways of modeling the smoking effect were explored, and the best-fitting model was one that included an indicator variable for smoking status (ever or never smoked) and separate continuous terms for duration, amount, and (duration)2. The log-likelihood ratio test was used to test the statistical significance of modeled effects. We also used this test to determine the significance of multiplicative interactions among certain variables with respect to lung cancer risk. The test compared a main effect, no interaction model with a fully parameterized model containing all possible interaction terms for the variables of interest. Gene dosage effects were modeled by assigning the value 1, 2, or 3 to the genotype variable according to the subject‘s number of vt alleles (zero, one, and two rare alleles, respectively).


   Results
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
Discussion
 REFERENCES
 
The study population consisted of 327 lung cancer cases and 440 population controls. The mean age was 64.5 years for cases and 65.1 years for controls. Forty % of subjects were Caucasians, 36% were Japanese, and 24% were Hawaiians. No significant differences were noted in the sex and ethnic distributions of the cases and controls who donated a blood sample. Other relevant characteristics of the study population have been reported previously (6) .

The frequency distribution of the wt and vt genotypes for NQO1 gene among lung cancer cases and controls is presented in Table 1Citation , overall and for each ethnic group. On the basis of the controls, the population frequency of the vt allele was 38% in Japanese, 20% in Caucasians, and 22% in Hawaiians. Overall, the genotype distribution was different in cases and controls (P = 0.07), and the vt allele was less common in cases compared with controls (P = 0.03). After stratification on ethnicity, the inverse association between the vt allele and lung cancer was statistically significant in Japanese (P = 0.04) and of borderline significance in Hawaiians (P = 0.05). No association was suggested in Caucasians P = 0.78) in this univariate analysis.


View this table:
[in this window]
[in a new window]

  		Table 1 Distribution of subjects by NQO1 genotype and ORs for lung cancer

 
The unadjusted OR for the wt/vt and vt/vt genotypes, compared with the wt/wt genotype, was 0.7 (95% CI: 0.5–1.1) and 0.4 (0.2–0.9), respectively, with a significant trend of decreasing risk with increasing number of vt alleles (P = 0.01). This trend did not persist after adjustment for covariates, although the point estimate of the OR for the vt/vt genotype remained unchanged (0.4; Table 1Citation ). A statistically significant inverse association was found in Japanese, with an OR of 0.3 (0.1– 0.7) for the vt/vt genotype compared with the wt/wt genotype, with a P for genetic trend of 0.02 (Table 1)Citation . A similar decrease in risk for the vt allele was also observed in the other two ethnic groups, with ORs of 0.8 (0.4–1.5) and 0.6 (0.2–1.3) for the combined wt/vt and vt/vt genotypes compared with the wt/wt genotype for Caucasians and Hawaiians, respectively (Table 1)Citation .

To assess whether the NQO1 vt allele may impart different risks for the various lung cancer cell types, we computed the adjusted ORs for lung cancer for each histological type (results not shown). No cell type specificity was detected because similar inverse associations were observed or suggested for adenocarcinoma (P for trend, 0.04), squamous cell carcinoma (P for trend, 0.07), and small cell carcinoma.

The interaction of NQO1 genotype (wt/wt versus wt/vt or vt/vt) and smoking history (<=28 versus >28 for pack-years, where 28 represents the median) on the risk of lung cancer was also assessed. The Ps for interaction for all cell types, squamous cell carcinoma, and adenocarcinoma were 0.58, 0.60, and 0.73, respectively, indicating an absence of interaction with the extent of smoking. Similarly, no interactions were found between NQO1 and intake of total vegetables or specific food sources of indoles and isothiocyanate (broccoli) or flavonoids (apples, onion, or green tea).


   Discussion
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
REFERENCES
 
Our previous epidemiological studies have demonstrated that ethnic variation in lung cancer incidence in Hawaii is not totally explained by differences in smoking exposure (2) . It is possible that genetic susceptibility may play a role in these risk differences. Recently, studies have reported associations between lung cancer and several genetic polymorphisms affecting the activities of enzymes involved in the metabolism of procarcinogens in tobacco smoke (4, 5, 6) . Although few of these past studies used a population-based design and adequately adjusted risk estimates for smoking, the evidence to date suggests that a number of polymorphic genes may play a role in the etiology of lung cancer (4, 5, 6) .

Considering the potential role of NQO1 in modulating tobacco smoke-related compounds (7, 8, 9, 10, 11) , we explored a possible association of the NQO1 609C->T mutation with lung cancer. We observed a statistically significant inverse association of this polymorphism with lung cancer in Japanese. The numbers of Caucasians and Native Hawaiians with the vt allele were too small to yield conclusive results in these ethnic groups, although the data were also consistent with an inverse association. In addition, we observed a marked ethnic variation in the prevalence of the NQO1 polymorphism. The vt NQO1 allele was almost twice as common in Japanese as in Caucasians. This difference in allele frequency and the inverse association between lung cancer and the NQO1 609C->T mutation, associated with a lower enzyme activity, are consistent with the lower lung cancer risk observed among Japanese smokers compared with Caucasian smokers (2) . Moreover, both the association of the NQO1 609->T mutation with lung cancer and the lower risk of Japanese smokers for this neoplasm, compared with Caucasian smokers, were observed for each main cell type of lung cancer (2) .

We are aware of only two previous studies of the NQO1 609C->T polymorphism and lung cancer. Wiencke et al. (14) conducted a case- control study among a hospital series of 177 lung cancer patients and a convenience sample of 297 controls of African- or Mexican-American ethnicity. Consistent with our results, they reported a direct association of lung cancer with the wt homozygous genotype (OR, 1.90; 95% CI, 1.04–3.46) in Mexican-Americans, compared with the other two combined genotypes. The association was weaker in African-Americans (OR, 1.36; 95% CI, 0.75–2.31). The vt allele was more common in Mexican-Americans (42%) than in African-Americans (22%), correlating with the risk of lung cancer among these ethnic groups (14) .

Roswold et al. (15) compared the frequency of the NQO1 609C->T mutation among a group of 150 predominantly white lung cancer patients, 82 unrelated individuals who were part of a reference series from the Centre d’Etude du Polymorphisme Humain, and 77 employees and volunteers from their institution. Contrary to our findings, the frequency of the NQO1 vt allele was found to be higher in lung cancer cases compared with the Centre d’Etude du Polymorphisme Humain controls (P = 0.02) but not compared with the local controls (P = 0.70; Ref. (15) . The data analysis did not include adjustment for lifetime history of smoking, which is known to induce NQO1. Other known NQO1 inducers include flavonoids, indoles, and isothiocyanate (17 , 18) . Thus, beside smoking, specific dietary exposures may confound the association of NQO1 with lung cancer. We were able to consider these factors as potential confounders and modifying variables in the present study.

The lower lung cancer risk observed in individuals with the vt allele (who are expected to have a decreased NQO1 activity) in this study is consistent with a role for NQO1 in the metabolic activation of putative lung carcinogens. In this regard, it should be noted that NQO1 has been shown to activate a class of nitrosamines including 1,6-, 1,3-, and 1,8-dinitropyrenes (19 , 20) . Laboratory studies have shown that these dinitropyrenes are potent lung carcinogens in rats (21 , 22) . Cigarette smoke condensate, treated with nitric oxide or Chinese cabbage pickles in vitro to induce nitrosation, has been shown to lead to the formation of 1-nitropyrene and 1,3-dinitropyrene (23) . Further study of the role of NQO1 in the metabolic activation of nitropyrene in lung carcinogenesis may help in better understanding the relationship of the NQO1 609C->T polymorphism and this disease in humans.


   ACKNOWLEDGMENTS
 
We thank the Hawaii Tumor Registry, Castle Medical Center, Kaiser-Permanente Medical Center, Kuakini Medical Center, Queen’s Medical Center, Straub Clinic and Hospital, St. Francis Medical Center, Tripler Medical Center, and Wahiawa General Hospital for their collaboration. We also thank Ronette Hunt, Barbara Burden, Geraldine Kaneshiro, and Yun Oh Jung for technical assistance.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research was supported in part by Grant RO1-CA-55874 and Contract NO1-PC-67001 from the National Cancer Institute and by Grant EDT-78 from the American Cancer Society. Back

2 To whom requests for reprints should be addressed, at Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Suite 407, Honolulu, HI 96813. Phone: (808) 586-2988; Fax: (808) 586-2982; Back

3 The abbreviations used are: NQO1, NAD(P)H:quinone oxidoreductase; OR, odds ratio; CI, confidence interval; wt, wild type; vt, variant. Back

Received 2/ 1/99. Accepted 5/13/99.


   REFERENCES
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Ed. 5 Miller B. A. Kolonel L. N. Bernstein L. Young J. L., Jr. Swanson G. M. West D. Key C. R. Liff J. M. Glover C. S. Alexander G. A. Coyle L. Hankey B. F. Gloeckler Ries L. A. Kosary C. L. Harras A. Percy C. Edwards B. K. eds. . Racial/Ethnic Patterns of Cancer in the United States 1988–1992, National Cancer Institute. NIH Publication No. 96-4104, : 72-75, NCI MD: Bethesda 1996.
  2. Le Marchand L., Wilkens L. R., Kolonel L. N. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol. Biomark. Prev., 1: 103-107, 1992.[Abstract]
  3. Harris C. C. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis (Lond.), 10: 1563-1566, 1989.[Abstract/Free Full Text]
  4. Uematsu F., Kikuchi H., Motomiy M., Abe T., Sagami I., Ohmachi T., Wakui A., Kanamaru R., Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. Cancer Res., 82: 254-256, 1991.[Medline]
  5. Ketterer B., Harris J. M., Talaska G., Meyer D.J., Pemble S. E., Taylor J. B., Lang N. P., Kadlubar F. F. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect., 98: 87-94, 1992.[Medline]
  6. Le Marchand L., Sivaraman L., Pierce L., Seifried A., Lum A., Wilkens L. R., Lau A. F. Associations of CYP1A1, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res., 58: 4858-4863, 1998.[Abstract/Free Full Text]
  7. De Flora S., Bennicelli C., D’Agostini F., Izzotti A., Camoirano A. Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B. Environ. Health Perspect., 102(SUPPL. 6): 69-74, 1994.
  8. Joseph P., Jaiswal A. K. NAD(P)H:quinone oxidoreductase 1 (DT-diaphorase) specifically prevents the formation of benzo [a]pyrene quinone-DNA adducts generated by cytochrome P450 1A1 and P450 reductase. Proc. Natl. Acad. Sci. USA, 91: 8413-8417, 1994.[Abstract/Free Full Text]
  9. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol., 49: 127-140, 1995.[Medline]
  10. Chen S., Knox R., Lewis A. D., Friedlos F., Workman P., Deng P. S., Fung M., Ebenstein D., Wu K., Tsai T. M. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes. Mol. Pharmacol., 47: 934-939, 1995.[Abstract]
  11. Cenas N., Nemeikaite A., Dickancaite E., Anusevicius Z., Nivinskas H., Bironaite D. The toxicity of aromatic nitrocompounds to bovine leukemia virus-transformed fibroblasts: the role of single-electron reduction. Biochem. Biophys. Acta, 1268: 159-164, 1995.[Medline]
  12. Traver R. D., Horikoshi T., Danenberg K. D., Stadlbauer T. H., Danenberg P. V., Ross D., Gibson N. W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res., 52: 797-802, 1992.[Abstract/Free Full Text]
  13. Traver R.D., Siegel D., Beall H. D., Phillips R. M., Gibson N. W., Franklin W. A., Ross D. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). Br. J. Cancer, 75: 69-75, 1997.[Medline]
  14. Wiencke J. K., Spitz M. R., McMillan A., Kelsey K. T. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Cancer Epidemiol. Biomark. Prev., 6: 87-92, 1997.[Abstract]
  15. Rosvold E. A., McGlynn K. A., Lustbader E. D., Buetow K. H. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics, 5: 199-206, 1995.[Medline]
  16. Breslow, N. E., and Day, N. E. Statistical Methods for Cancer Epidemiology. The Analysis of Case-Control Studies, Vol. I., IARC Scientific Publication No. 32. Lyon: IARC, 1980.
  17. Jaiswal A. K. Jun and Fos regulation of NAD(P)H:quinone oxidoreductase gene expression. Pharmacogenetics, 4: 1-10, 1994.[Medline]
  18. Talalay P., DeLong M. J., Prochaska H. J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA, 85: 8261-8265, 1988.[Abstract/Free Full Text]
  19. Hajos A. K., Winston G. W. Dinitropyrene nitroreductase activity of purified NAD(P)H-quinone oxidoreductase: role in rat liver cytosol and induction by Aroclor-1254 pretreatment. Carcinogenesis (Lond.), 12: 697-702, 1991.[Abstract/Free Full Text]
  20. Winston G. W., Traynor C. A., Shane B. S., Hajos A. K. Modulation of the mutagenicity of three dinitropyrene isomers in vitro by rat-liver S9, cytosolic, and microsomal fractions following chronic ethanol ingestion. Mutat. Res., 279: 289-298, 1992.[Medline]
  21. Maeda T., Izumi K., Otsuka H., Manabe Y., Kinouchi T., Ohnishi Y. Induction of squamous cell carcinoma in the rat lung by 1,6-dinitropyrene. J. Natl. Cancer Inst., 76: 693-701, 1986.
  22. Iwagawa M., Maeda T., Izumi K., Otsuka H., Nishifuji K., Ohnishi Y., Aoki S. Comparative dose-response study on the pulmonary carcinogenicity of 1,6-dinitropyrene and benzo[a]pyrene in F344 rats. Carcinogenesis (Lond.), 10: 1285-1290, 1989.[Abstract/Free Full Text]
  23. Sera N., Tokiwa H., Hirohata T. Induction of nitroarenes in cigarette smoke condensate treated with nitrate. Toxicol. Lett., 50: 289-298, 1990.[Medline]



This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
S. Sasaki, F. Sata, S. Katoh, Y. Saijo, S. Nakajima, N. Washino, K. Konishi, S. Ban, M. Ishizuka, and R. Kishi
Adverse Birth Outcomes Associated with Maternal Smoking and Polymorphisms in the N-Nitrosamine-Metabolizing Enzyme Genes NQO1 and CYP2E1
Am. J. Epidemiol., March 15, 2008; 167(6): 719 - 726.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote
The molecular epidemiology of lung cancer
Carcinogenesis, March 1, 2007; 28(3): 507 - 518.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Begleiter, D. Hewitt, A. W. Maksymiuk, D. A. Ross, and R. P. Bird
A NAD(P)H:Quinone Oxidoreductase 1 Polymorphism Is a Risk Factor for Human Colon Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2422 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. Ahn, G. Sethi, A. K. Jain, A. K. Jaiswal, and B. B. Aggarwal
Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-{kappa}B, I{kappa}B{alpha} Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis
J. Biol. Chem., July 21, 2006; 281(29): 19798 - 19808.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Chao, Z.-F. Zhang, J. Berthiller, P. Boffetta, and M. Hashibe
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 979 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. A. Lawson, K. Woodson, J. Virtamo, and D. Albanes
Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C->T Polymorphism with Lung Cancer Risk among Male Smokers
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2275 - 2276.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Li, Z. Liu, E. M. Sturgis, R. M. Chamberlain, M. R. Spitz, and Q. Wei
CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu Polymorphisms Are Not Associated with Risk of Squamous Cell Carcinoma of the Head and Neck
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1034 - 1036.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-i. Fukumoto, N. Yamauchi, H. Moriguchi, Y. Hippo, A. Watanabe, J. Shibahara, H. Taniguchi, S. Ishikawa, H. Ito, S. Yamamoto, et al.
Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas
Clin. Cancer Res., March 1, 2005; 11(5): 1776 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.H. Bock, A.S. Wenzlaff, M.L. Cote, S.J. Land, and A.G. Schwartz
NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study
Carcinogenesis, February 1, 2005; 26(2): 381 - 386.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A.-K. Alexandrie, F. Nyberg, M. Warholm, and A. Rannug
Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 908 - 914.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. G. Schwartz
Genetic Predisposition to Lung Cancer
Chest, May 1, 2004; 125(5_suppl): 86S - 89S.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Stiborova, E. Frei, B. Sopko, K. Sopkova, V. Markova, M. Lankova, T. Kumstyrova, M. Wiessler, and H. H. Schmeiser
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
Carcinogenesis, October 1, 2003; 24(10): 1695 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Zhang, W. A. Schulz, Y. Li, R. Wang, R. Zotz, D. Wen, D. Siegel, D. Ross, H. E. Gabbert, and M. Sarbia
Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population
Carcinogenesis, May 1, 2003; 24(5): 905 - 909.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
F. Zappa, T. Ward, E. Pedrinis, J. Butler, and A. McGown
NAD(P)H:Quinone Oxidoreductase 1 Expression in Kidney Podocytes
J. Histochem. Cytochem., March 1, 2003; 51(3): 297 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota
Contribution of the NQO1 and GSTT1 Polymorphisms to Lung Adenocarcinoma Susceptibility
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 730 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
B. N Ames, I. Elson-Schwab, and E. A Silver
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms
Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Stiborova, E. Frei, B. Sopko, M. Wiessler, and H. H. Schmeiser
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy
Carcinogenesis, April 1, 2002; 23(4): 617 - 625.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. D. Gilliland, H. J. Harms, R. E. Crowell, Y.-F. Li, R. Willink, and S. A. Belinsky
Glutathione S-Transferase P1 and NADPH Quinone Oxidoreductase Polymorphisms Are Associated with Aberrant Promoter Methylation of P16INK4a and O6-Methylguanine-DNA Methyltransferase in Sputum
Cancer Res., April 1, 2002; 62(8): 2248 - 2252.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Strassburg, C. P. Strassburg, M. P. Manns, and R. H. Tukey
Differential Gene Expression of NAD(P)H:Quinone Oxidoreductase and NRH:Quinone Oxidoreductase in Human Hepatocellular and Biliary Tissue
Mol. Pharmacol., February 1, 2002; 61(2): 320 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
O. H. Kantarci, T. G. Lesnick, P. Yang, R. L. Meyer, D. D. Hebrink, C. T. McMurray, and B. G. Weinshenker
Myeloperoxidase -463 (G(R)A) Polymorphism Associated With Lower Risk of Lung Cancer
Mayo Clin. Proc., January 1, 2002; 77(1): 17 - 22.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. L. Xu, J. C. Wain, D. P. Miller, S. W. Thurston, L. Su, T. J. Lynch, and D. C. Christiani
The NAD(P)H:quinone Oxidoreductase 1 Gene Polymorphism and Lung Cancer: Differential Susceptibility Based on Smoking Behavior
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 303 - 309.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. S. Brar, T. P. Kennedy, A. R. Whorton, A. B. Sturrock, T. P. Huecksteadt, A. J. Ghio, and J. R. Hoidal
Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-{kappa}B in malignant melanoma cells
Am J Physiol Cell Physiol, March 1, 2001; 280(3): C659 - C676.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.J. Lafuente, X. Casterad, M. Trias, C. Ascaso, R. Molina, A. Ballesta, S. Zheng, J.K. Wiencke, and A. Lafuente
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors
Carcinogenesis, October 1, 2000; 21(10): 1813 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Naoe, K. Takeyama, T. Yokozawa, H. Kiyoi, M. Seto, N. Uike, T. Ino, A. Utsunomiya, A. Maruta, I. Jin-nai, et al.
Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia
Clin. Cancer Res., October 1, 2000; 6(10): 4091 - 4095.
[Abstract] [Full Text]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Marchand, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Marchand, L. L.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online